|
|
| | Closely watched Parkinson's drug from Biogen, Denali comes up short (biopharmadive.com) | | 1 point by randycupertino 4 months ago | past | 1 comment | |
| | Hims cancels plans to sell compounded GLP-1 pill after FDA backlash (biopharmadive.com) | | 5 points by randycupertino 7 months ago | past | 2 comments | |
| | Pharvaris' pill succeeds in late-stage trial for rare swelling disorder (biopharmadive.com) | | 1 point by andsoitis 9 months ago | past | |
| | 'The bar has risen': China's biotech gains push US companies to adapt (biopharmadive.com) | | 1 point by CalmStorm on July 15, 2025 | past | |
| | Patient dies in trial of Rocket gene therapy for heart condition (biopharmadive.com) | | 1 point by randycupertino on May 28, 2025 | past | |
| | Duchenne approval exposes FDA rift over Sarepta gene therapy (biopharmadive.com) | | 1 point by jyunwai on June 21, 2024 | past | |
| | Lilly Alzheimer's drug gets unanimous backing of FDA panel (biopharmadive.com) | | 8 points by gmays on June 20, 2024 | past | 1 comment | |
| | Non-opioid drug from Vertex cuts pain in major trial tests (biopharmadive.com) | | 2 points by gmays on Feb 1, 2024 | past | 1 comment | |
| | How Amgen built a patent thicket around its top-selling drug (biopharmadive.com) | | 1 point by watersb on Nov 1, 2021 | past | |
| | Intellia, with first results, delivers a 'landmark' for CRISPR gene editing (biopharmadive.com) | | 2 points by elsewhen on June 27, 2021 | past | |
| | Two patients die in now-halted study of Audentes gene therapy (biopharmadive.com) | | 3 points by aaavl2821 on June 27, 2020 | past | |
| | Bankrupt biopharmas are rare. 2019 has some worried that’s changing (biopharmadive.com) | | 3 points by eli on Nov 19, 2019 | past | |
| | No magic pill for obesity: Orexigen files for bankruptcy (biopharmadive.com) | | 2 points by Ice_cream_suit on March 20, 2018 | past | |
|
Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact
|
